Sertralinum
Cave: notitiae huius paginae nec praescriptiones nec consilia medica sunt. |
Natura chemica | |
---|---|
Formula chemica | C 17H 17Cl 2N |
Massa molaris | 306.229 g/mol |
PubChem | 68617 |
DrugBank | DB01104 |
Natura pharmacologica | |
Codex ATC | N06AB06 (WHO) |
Tempus semivitae biologicum | ~23–26 h |
Metabolismus | iecore (hepaticus): CYP2B6 |
Metabolitus | Desmethylo-sertralinum |
Excretio | renibus |
Ad usum therapeuticum | |
Applicatio | per os |
MedlinePlus | a697048 (Anglice) |
Sertralinum est substantia psychoanaleptica, antidepressiva et inhibitor reabsorptionis serotonini selectivus. Quae ad conturbationem obsessionem-compulsionem et phobias curandas adhibetur.
Historia
[recensere | fontem recensere]Anno 1978 chemicus Willard Welsh societatis Pfizer mixturam Sertralini et enantiomerium eius fecit[1][2]. Intra unum mensem Welsh enantiomeres inactivos removit, ut Sertralinum primus inhibitor reabsorptionis Serotonini selectivus purus fuerit. Anno 1991 Sertralinum in mercatum introductum est.
Natura Sertralini
[recensere | fontem recensere]Natura chemica
[recensere | fontem recensere]Sertralinum est naphtylaminum cuius structura chemica (1S,4S)-4-(3,4-dichlorophenyl)-N-methyl-1,2,3,4-tetrahydronaphthalen-1-aminum et massa molaris 306.229 g/mol est. Codex ATC est N06AB06.
Natura pharmacologica
[recensere | fontem recensere]Pharmacodynamica
[recensere | fontem recensere]Sertralinum imprimis inhibitor reabsorptionis serotonini affinitate sui notate cum transportatro serotonini (SERT) est, Ki = 2.0 habens[3]. Novem mg/die sufficit ut transportatrorum dimidium serotonini impediatur[4].
Pharmacocinetica
[recensere | fontem recensere]Tempus semivitae biologicum est circa 25 horae.[5] Sertralinum substratum cytochromatum, imprimis CYP2B6, minor CYP3A4 et CYP2C19, est[6]. Excretio est per urinas.
Usus Sertralini
[recensere | fontem recensere]Toxicitas
[recensere | fontem recensere]Dosis letalis [7] 2800-7000 mg/kg homini (mus: 336) est.
Effectus usu
[recensere | fontem recensere]Reactiones adversae
[recensere | fontem recensere]Nexus interni
Notae
[recensere | fontem recensere]- ↑ Willard M. Welch (1995). Discovery and preclinical development of the serotonin reuptake inhibitor sertraline. Advances in Medicinal Chemistry 3: 113-148
- ↑ JJ Li (2009). Triumph of the heart. The Story of Statins. Oxford University Press. Pag. 135
- ↑ http://www.abcam.com/Sertraline-hydrochloride-ab141068.pdf
- ↑ Meyer JH, Wilson AA, Sagrati S, Hussey D, Carella A, Potter WZ, Ginovart N, Spencer EP, Cheok A, Houle S (2004). Serotonin transporter occupancy of five selective serotonin reuptake inhibitors at different doses: an [11C]DASB positron emission tomography study. Am J Psych 161 (5): 826–35
- ↑ Fons.
- ↑ Obach R. S., Cox L. M., Tremaine L. M. (2005). "Sertraline is metabolized by multiple cytochrome P450 enzymes, monoamine oxidases, and glucuronyl transferases in human: an in vitro study". Drug Metab Dispos 33 (2): 262-70
- ↑ Shinkei Seishin Yakuri (1997). Neuropsychopharmacology. Bd. 19, S. 395
- ↑ Varela Piñón M., Adán-Manes J. (2017). "Selective Serotonin Reuptake Inhibitor-Induced Hyponatremia: Clinical Implications and Therapeutic Alternatives". Clinical neuropharmacology 40 (4): 177-9